Clinical Trials Directory

Trials / Completed

CompletedNCT06470555

Haemostasis After Venous Access in Atrial Fibrillation Catheter Ablation: The HARNESS Trial

A Randomised Controlled Trial to Compare Manual Compression and Suture-mediated Haemostasis After Catheter Ablation of Atrial Fibrillation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
336 (actual)
Sponsor
Liverpool Heart and Chest Hospital NHS Foundation Trust · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Atrial fibrillation (AF) is the most common heart rhythm disorder affecting adults in the United Kingdom. In patients with AF who continue to experience symptoms despite medications, catheter ablation is an established interventional treatment. Ablation is performed by inserting a number of plastic tubes in the veins in the groin, in order to access the heart. Despite continued advances in equipment and techniques, groin complications remain the most common complications after AF ablation. The severity of these can range from minor (e.g. bleeding resolvable with manual pressure) to major (bleeding requiring blood transfusion, prolonged hospitalisation, intervention, or rarely resulting in death). Following ablation, the plastic tubes in the groin are removed before leaving the procedure room. Once removed, the doctor will stop the bleeding in the groin. There are two commons ways in which the doctor can stop the bleeding: 1) conventional treatment with manual compression - the doctor applies pressure with their hands to the groin area to stop the bleeding; 2) suture treatment (also known as a "stitch") - the doctor inserts a suture to the groin area and secures this in place with a small plastic device (called a three-way tap). The suture and three-way tap are left in place for a few hours before being removed. Both of these methods are commonly in use. However, there is no high-quality evidence to support whether one way is better than the other. After stopping the bleeding, patients are generally asked to lay flat for 4 hours to prevent any bleeding. It is not known whether this duration can safely be shortened. The Haemostasis AfteR veNous accESS in AF catheter ablation (HARNESS) trial is a pragmatic, single-centre, open label, randomised controlled trial which will compare a suture with a three-way tap to manual compression, and examine the impact of bed rest duration on clinical outcomes.

Conditions

Interventions

TypeNameDescription
OTHERA figure-of-eight suture secured with a three-way tapFemoral haemostasis using a figure-of-eight suture technique
OTHERShortened bed rest duration of 2-hoursBed rest duration of 2-hours after initial haemostasis
OTHERManual compressionFemoral haemostasis using manual compression
OTHERConventional bed rest duration of 4-hoursBed rest duration of 4-hours after initial haemostasis

Timeline

Start date
2024-08-27
Primary completion
2025-07-18
Completion
2025-07-18
First posted
2024-06-24
Last updated
2025-07-29

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT06470555. Inclusion in this directory is not an endorsement.